News
Sanofi and Regeneron Pharmaceuticals, Inc. presented positive results from the EVEREST phase 4 study of adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting asthma. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback